Sodium Iodide → 4-Phenyl-1-(2-(4,5,6,7-tetrahydrobenzo[b]thien-4-yl)ethyl)piperidine
Reaction equation
Cl[CH2:2][CH2:3][CH:4]1[C:12]2[CH:11]=[CH:10][S:9][C:8]=2[CH2:7][CH2:6][CH2:5]1.Cl.[C:14]1([CH:20]2[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]2)[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1.C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>CN(C=O)C>[C:14]1([CH:20]2[CH2:21][CH2:22][N:23]([CH2:2][CH2:3][CH:4]3[C:12]4[CH:11]=[CH:10][S:9][C:8]=4[CH2:7][CH2:6][CH2:5]3)[CH2:24][CH2:25]2)[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 4-(2-chloroethyl)-4,5,6,7-tetrahydrobenzo[b]thiophene (0.25 g, 1.24 mmol), 4-phenylpiperidine hydrochloride (0.25 g, 1.25 mmol), K2CO3 (0.40 g, 2.89 mmol) and a catalytic amount of NaI in DMF (5 mL) is heated to 110° C. overnight. The solvent is removed at reduced pressure, diethyl ether is added to the residue and washed with water. The organic phase is dried and evaporated at reduced pressure and the resulting crude is purified by column chromatography, giving 4-phenyl-1-(2-(4,5,6,7-tetrahydrobenzo[b]thien-4-yl)ethyl)piperidine (0.24 g, 0.74 mmol, 59%, oil). 1H NMR (300 MHz, CDCl3): δ 1.54 (m, 1H), 1.70-2.18 (m, 11H), 2.51 (m, 3H), 2.76 (m, 3H), 3.12 (m, 2H), 6.88 (d, J=5.2 Hz, 1H), 7.04 (d, J=5.2 Hz, 1H), 7.18-7.32 (m, 5H).
Workup
- customThe solvent is removed at reduced pressure, diethyl ether
- additionis added to the residue
- washwashed with water
- customThe organic phase is dried
- customevaporated at reduced pressure
- customthe resulting crude is purified by column chromatography
Sources & evidence
- ORD record
- ord-7e0868c35c5c4514baf696adc346398f
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08492563B2
Reaction notes
Loading…